Key Metrics
6.7
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
0.001 - 0.005
Eigenfactor
Eigenfactor
Eigenfactor Score measures the number of times articles from the journal published in the past five years have been cited. This does not include self citations.
5 - 10
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
0.93
5-Year SI
5-year SI
- N/A 2-year SI
- 0.93 Lifetime SI
Scite Index
Scite Index
scite Index is the ratio of citations supporting research which is published in the journal to sum of citations either supporting or contrasting the research published in the journal for the same time period. Minimum 100 supporting citations required.
Q3
Oncology
SJR
- Q2 Oncology
- Q3 Cancer Research
- Q3 Molecular Medicine
- Q2 Pharmacology (medical)
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
1.02
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
5 Mo
Time to Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time To Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
% of papers by time taken from submission to publication
0 to 3 months
3%
4 to 6 months
57%
7 to 9 months
30%
Above 9 months
10%
Did you find this useful?
Thank you for your feedback.
Indexed in the following public directories
-
Web of Science -
Scopus -
DOAJ -
SJR
Topics Covered
- Virus
- Breast cancer
- Immunotherapy
- Human cancer
- Osteosarcoma
- Hepatocellular carcinoma
- Overall survival
- Tumor microenvironment
- Neuroblastoma
- Toxicity
- Oncolytic adenovirus
- Tumor growth
- Metformin
- Cisplatin
- Vaccinia
- Autophagy
- Epidermal growth factor receptor
- Antigen
- Chemotherapy resistance
- Meningioma
Journal Specifications
| Overview | |
| Publisher | CELL PRESS |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | USD 3900 |
| Publication Time | 6 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | American Society for Gene and Cell Therapies |
| Frequency | Continuous publication |
| Publication Start Year | 2014 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Other charges | Visit website |
| Plagiarism | Visit website |
| Waiver Policy | Visit website |
| Publication Time | 6 |
| Article Processing Charges | USD 3900 |
| Editorial Review Detail | |
| Editorial Team | Visit website |
| Review Process | Anonymous peer review |
| Review Url | Visit website |
| Information for authors | |
| Author instructions | Visit website |
| License type | CC BY, CC BY-NC-ND |
| OA statement | Visit website |
Planning to publish in Molecular Therapy - Oncolytics ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Thank you to our 2023 reviewers
- 1 Dec 23
- Molecular Therapy - Oncolytics
-
Full paper
Gaining insights into virotherapy with canine models
- 1 Dec 23
- Molecular Therapy - Oncolytics
-
Full paper
Targeting mesothelin in cancer
- 1 Dec 23
- Molecular Therapy - Oncolytics
-
Full paper
MiR-146a: Overcoming coldness in ovarian cancer
- 1 Dec 23
- Molecular Therapy - Oncolytics
-
Full paper
New advances in cancer therapy targeting TGF-β signaling pathways
- 1 Dec 23
- Molecular Therapy - Oncolytics
-
Full paper
The role and application of vesicles in triple-negative breast cancer: Opportunities and challenges
- 23 Nov 23
- Molecular Therapy - Oncolytics
Scite analysis
Powered by scite_
819 articles received 14.5k citations see all
- 361 Supporting
- 14,008 Mentioning
- 24 Contrasting
Editorial notices
- 3 Retractions
- 0 Withdrawals
- 0 Corrections
- 13 Errata
- 0 Expression of Concern
FAQs
How long has Molecular Therapy - Oncolytics been actively publishing?
Molecular Therapy - Oncolytics has been in operation since 2014 till date.
What is the publishing frequency of Molecular Therapy - Oncolytics ?
Molecular Therapy - Oncolytics published with a Continuous publication frequency.
How many articles did Molecular Therapy - Oncolytics publish last years ?
In 2023, Molecular Therapy - Oncolytics published 93 articles.
What is the eISSN & pISSN for Molecular Therapy - Oncolytics ?
For Molecular Therapy - Oncolytics,eISSN is 2372-7705 and pISSN is2372-7705.
What is Citescore for Molecular Therapy - Oncolytics ?
Citescore for Molecular Therapy - Oncolytics is 6.7.
What is SNIP score for Molecular Therapy - Oncolytics ?
SNIP score for Molecular Therapy - Oncolytics is 1.02.
What is the SJR for Molecular Therapy - Oncolytics ?
SJR for Molecular Therapy - Oncolytics is Q3.
Who is the publisher of Molecular Therapy - Oncolytics ?
CELL PRESS is the publisher of Molecular Therapy - Oncolytics.